U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4527145271Transcranial Magnetic Stimulation in the Treatment of AddictionNot yet recruitingNo Results AvailableAlcohol AddictionOther: Verum rTMS|Other: Sham rTMShttps://ClinicalTrials.gov/show/NCT01973127
4527245272Latanoprost for the Treatment of Menière's DiseaseRecruitingNo Results AvailableMenière's DiseaseDrug: Latanoprost|Other: Placebohttps://ClinicalTrials.gov/show/NCT01973114
4527345273Non-comparative Study of Treatment With Induction Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation or Definitive Chemoradiation in Invasive Locally Advanced Carcinomas of Uterine Cervix.RecruitingNo Results AvailablePatients Diagnosed With Advanced Carcinoma of Uterine Cervix tDrug: Cisplatin|Drug: Gemcitabine|Drug: cisplatin|Radiation: Radiotherapy|Radiation: Brachytherapyhttps://ClinicalTrials.gov/show/NCT01973101
4527445274Screening and Identification of Human Urate Transporter hURAT1 MicroRNAActive, not recruitingNo Results AvailableUrinary Calculihttps://ClinicalTrials.gov/show/NCT01973088
4527545275Genetic Etiology in Premature Ovarian InsufficiencyRecruitingNo Results AvailablePrimary Ovarian Insufficiency|Genetic Predisposition to Diseasehttps://ClinicalTrials.gov/show/NCT01973075
4527645276Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Primary Central Nervous System Non-Hodgkin LymphomaTerminatedNo Results AvailablePrimary Central Nervous System Non-Hodgkin LymphomaBiological: rituximab|Radiation: yttrium Y 90 ibritumomab tiuxetanhttps://ClinicalTrials.gov/show/NCT01973062
4527745277UNITY 2: A Study of an Investigational Treatment Regimen of DCV+ASV+BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) With or Without RBV for 12 Weeks for the Treatment of Chronic Hepatitis C Virus(HCV)Genotype 1 InfeCompletedNo Results AvailableHepatitis CDrug: Daclatasvir|Drug: Asunaprevir|Drug: BMS-791325|Drug: Ribavirin|Drug: Placebo matching Ribavirinhttps://ClinicalTrials.gov/show/NCT01973049
4527845278FOLCROM Trial: Foley Catheter in Rupture of MembranesRecruitingNo Results AvailablePremature Rupture of Membranes|Cervical RipeningDevice: Foley Catheter|Drug: Oxytocinhttps://ClinicalTrials.gov/show/NCT01973036
4527945279Stroke's Gait Pattern Modifications of Induced by Repeated BTICompletedNo Results AvailableEffect of Repeated Botulinum Toxin Injection on Gait Pattern in Stroke PatientsOther: Motion analysishttps://ClinicalTrials.gov/show/NCT01973023
4528045280Massage Therapy for Chronic Low Back PainCompletedNo Results AvailableLow Back PainOther: Massage|Drug: Ibuprofenhttps://ClinicalTrials.gov/show/NCT01973010
4528145281SENSIMED Triggerfish Sensor SizesCompletedNo Results AvailableHealthy VolunteersDevice: SENSIMED Triggerfishhttps://ClinicalTrials.gov/show/NCT01972997
4528245282Feasibility Study of Presurgical Hormone Therapy (Anastrozole) in Breast Cancer PatientsCompletedNo Results AvailableBreast CancerDrug: Anastrozolehttps://ClinicalTrials.gov/show/NCT01972984
4528345283To Establish a Novel Prototype of Clinical Pharmacy Services by Warfarin Consultation in a Pharmacist ClinicRecruitingNo Results AvailableIntentional Warfarin Sodium OverdoseOther: patient educationhttps://ClinicalTrials.gov/show/NCT01972971
4528445284Effects of Community Health Programs by Nurses for Older AdultsCompletedNo Results AvailableOlder AdultsOther: comprehensive carehttps://ClinicalTrials.gov/show/NCT01972958
4528545285Vaginoscopy Against Standard Treatment (VAST): a Randomised Controlled TrialRecruitingNo Results AvailableHysteroscopy TechniqueProcedure: Vaginoscopy|Procedure: Standard Hysteroscopyhttps://ClinicalTrials.gov/show/NCT01972945
4528645286Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated DiarrheaTerminatedNo Results AvailableClostridium Difficile Infection|Antibiotic Associated DiarrheaDietary Supplement: Bio-K®https://ClinicalTrials.gov/show/NCT01972932
4528745287MR Guided Dose Escalated RT + Concurrent Chemotherapy in Unresectable Pancreatic CancerNot yet recruitingNo Results AvailableUnresectable Pancreatic CancerRadiation: Radiation Therapy|Drug: Concurrent chemotherapy (Gemcitabine, Capecitabine)https://ClinicalTrials.gov/show/NCT01972919
4528845288Moxibustion for Primary DysmenorrheaCompletedNo Results AvailablePrimary DysmenorrheaDevice: moxibustion|Drug: Ibuprofen Sustained Release Capsuleshttps://ClinicalTrials.gov/show/NCT01972906
4528945289A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy VolunteersCompletedNo Results AvailableType 2 Diabetes MellitusDrug: ZYD1|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01972893
4529045290A Study to Compare the Oral Absorption of ASP1941 Among Two Types of TabletsCompletedNo Results AvailableHealthy|Plasma Concentration of ASP1941Drug: ASP1941https://ClinicalTrials.gov/show/NCT01972880
4529145291Pilot Study of NanoKnife for Ablation of Prostate Cancer in Low Risk PatientsRecruitingNo Results AvailableProstate CancerDevice: NanoKnife Procedurehttps://ClinicalTrials.gov/show/NCT01972867
4529245292A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With KeratoconusActive, not recruitingNo Results AvailableKeratoconusDrug: riboflavin: 0.12% riboflavin ophthalmic solution with the KXL system|Drug: placebo: 0.0% riboflavin opthalmic solution with the KXL systemhttps://ClinicalTrials.gov/show/NCT01972854
4529345293This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive BladderActive, not recruitingNo Results AvailableOveractive Bladder|Urgency Incontinence|Urinary Bladder Overactive|Urinary Bladder Diseases\Urologic DiseasesDrug: Solifenacin Succinate|Drug: Mirabegron|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01972841
4529445294Early Haemodynamic Optimization Using Preload Dependence During Septic Shock = EHOSS-1CompletedNo Results AvailableSeptic ShockDrug: FLUID MANAGEMENT GUIDED WITH PRELOAD-DEPENDENCE PARAMETERS (VOLUVEN ®)|Drug: STANDARD-GUIDED FLUID MANAGEMENT (VOLUVEN ®)https://ClinicalTrials.gov/show/NCT01972828
4529545295Reproducibility and Reliability of Epstein-Barr Virus (EBV) DNA/RNA Measures in Nasopharyngeal SwabsRecruitingNo Results AvailableSuspect NPC Patients|NPC Multiplex Familieshttps://ClinicalTrials.gov/show/NCT01972815
4529645296International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) StudyRecruitingNo Results AvailableEvaluate the Association Between Certain Environmental Exposures (e.g. Cigarette Smoking, Alcohol Drinking, Betel Nut Chewing…) and Head and Neck Cancers|Assess the Effect of Genetic Factors, Including Both SNP and Copy Number Variation (CNV) Through Anhttps://ClinicalTrials.gov/show/NCT01972802
4529745297Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Primarily Intra-retinal Fluid) Treatment.RecruitingNo Results AvailableSubfoveal Choroidal Neovascularization (CNV) Secondary to Wet Age-related Macular Degeneration (AMD)Drug: Ranibizumabhttps://ClinicalTrials.gov/show/NCT01972789
4529845298A Safety, Tolerability and Efficacy Study in COPD Patients With QBM076.RecruitingNo Results AvailableCOPDDrug: QBM076|Drug: placebohttps://ClinicalTrials.gov/show/NCT01972776
4529945299Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.RecruitingNo Results AvailableRecalcitrant Wet Age-related Macular DegenerationDrug: Ranibizumabhttps://ClinicalTrials.gov/show/NCT01972763
4530045300Dovitinib (TKI258) in the Treatment of Patients With Relapsed GlioblastomaRecruitingNo Results AvailableFirst or Second Recurrence of GlioblastomaDrug: Dovitinibhttps://ClinicalTrials.gov/show/NCT01972750

* Görseller ve İçerik tekif hakkına sahip olabilir